Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | APEX nuclease (multifunctional DNA repair enzyme) 1 | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0023 | 0.1385 | 0.5 |
Toxoplasma gondii | t-complex protein beta subunit | 0.0024 | 0.1522 | 0.4674 |
Echinococcus granulosus | intermediate filament protein | 0.0026 | 0.1952 | 0.0658 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0026 | 0.1952 | 0.1952 |
Echinococcus multilocularis | lamin | 0.0026 | 0.1952 | 0.0658 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 1 | 1 |
Trypanosoma brucei | T-complex protein 1, beta subunit, putative | 0.0024 | 0.1522 | 0.4674 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 1 | 1 |
Brugia malayi | T-complex protein 1, beta subunit | 0.0024 | 0.1522 | 0.1522 |
Echinococcus granulosus | chaperonin containing TCP1 subunit 2 beta | 0.0024 | 0.1522 | 0.0159 |
Echinococcus granulosus | lamin dm0 | 0.0026 | 0.1952 | 0.0658 |
Leishmania major | T-complex protein 1, beta subunit, putative | 0.0024 | 0.1522 | 0.4674 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.1678 | 1 |
Onchocerca volvulus | 0.0026 | 0.1952 | 0.5 | |
Onchocerca volvulus | 0.0026 | 0.1952 | 0.5 | |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0023 | 0.1385 | 0.1385 |
Echinococcus multilocularis | lamin dm0 | 0.0026 | 0.1952 | 0.0658 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0023 | 0.1385 | 0.5 |
Schistosoma mansoni | lamin | 0.0026 | 0.1952 | 0.0658 |
Schistosoma mansoni | chaperonin containing t-complex protein 1 beta subunit tcpb | 0.0024 | 0.1522 | 0.0159 |
Brugia malayi | TAR-binding protein | 0.0076 | 1 | 1 |
Echinococcus multilocularis | musashi | 0.0026 | 0.1952 | 0.0658 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.1678 | 1 |
Trichomonas vaginalis | chaperonin-60kD, ch60, putative | 0.0024 | 0.1522 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 1 | 1 |
Brugia malayi | T-complex protein 1, beta subunit | 0.0024 | 0.1522 | 0.1522 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0023 | 0.1385 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 1 | 1 |
Schistosoma mansoni | chaperonin containing t-complex protein 1 beta subunit tcpb | 0.0024 | 0.1522 | 0.0159 |
Schistosoma mansoni | lamin | 0.0026 | 0.1952 | 0.0658 |
Plasmodium vivax | T-complex protein 1 subunit beta, putative | 0.0024 | 0.1522 | 0.4674 |
Loa Loa (eye worm) | T-complex protein 1 | 0.0024 | 0.1522 | 0.1522 |
Echinococcus granulosus | lamin | 0.0026 | 0.1952 | 0.0658 |
Brugia malayi | intermediate filament protein | 0.0026 | 0.1952 | 0.1952 |
Brugia malayi | hypothetical protein | 0.0025 | 0.1678 | 0.1678 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.1678 | 1 |
Entamoeba histolytica | T-complex protein 1 beta subunit, putative | 0.0024 | 0.1522 | 1 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0285 | 0.0285 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.1678 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.1678 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0023 | 0.1385 | 0.1385 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 1 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.1875 | 0.1875 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.1678 | 1 |
Echinococcus multilocularis | chaperonin containing TCP1, subunit 2 (beta) | 0.0024 | 0.1522 | 0.0159 |
Giardia lamblia | TCP-1 chaperonin subunit beta | 0.0024 | 0.1522 | 1 |
Schistosoma mansoni | chaperonin containing t-complex protein 1 beta subunit tcpb | 0.0024 | 0.1522 | 0.0159 |
Plasmodium falciparum | T-complex protein 1 subunit beta | 0.0024 | 0.1522 | 0.4674 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0026 | 0.1952 | 0.1952 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 1 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.1678 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.1952 | 0.1952 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.1678 | 0.1678 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 1 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.1678 | 1 |
Trichomonas vaginalis | chaperonin, putative | 0.0024 | 0.1522 | 1 |
Schistosoma mansoni | intermediate filament proteins | 0.0026 | 0.1952 | 0.0658 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0026 | 0.1952 | 0.1952 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0023 | 0.1385 | 0.5 |
Trypanosoma cruzi | T-complex protein 1, beta subunit, putative | 0.0024 | 0.1522 | 0.4674 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.0004 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.